Designer Drugs for Designer Receptors: Unlocking the Translational Potential of Chemogenetics
Standard
Designer Drugs for Designer Receptors: Unlocking the Translational Potential of Chemogenetics. / Yizhar, Ofer; Wiegert, J Simon.
in: TRENDS PHARMACOL SCI, Jahrgang 40, Nr. 6, 06.2019, S. 362-364.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Designer Drugs for Designer Receptors: Unlocking the Translational Potential of Chemogenetics
AU - Yizhar, Ofer
AU - Wiegert, J Simon
N1 - Editorial Material
PY - 2019/6
Y1 - 2019/6
N2 - Chemogenetic techniques allow selective manipulation of neurons by activating engineered actuator proteins with otherwise inert effector molecules. A recent study (Magnus et al. Science 2019;364:eaav5282) describes the coevolution of highly potent actuator-effector pairs based on a clinically approved antismoking drug. These tools allow selective excitation or inhibition of neurons in the living brain with high specificity and no detectable side-effects.
AB - Chemogenetic techniques allow selective manipulation of neurons by activating engineered actuator proteins with otherwise inert effector molecules. A recent study (Magnus et al. Science 2019;364:eaav5282) describes the coevolution of highly potent actuator-effector pairs based on a clinically approved antismoking drug. These tools allow selective excitation or inhibition of neurons in the living brain with high specificity and no detectable side-effects.
U2 - 10.1016/j.tips.2019.04.010
DO - 10.1016/j.tips.2019.04.010
M3 - Other (editorial matter etc.)
C2 - 31072638
VL - 40
SP - 362
EP - 364
JO - TRENDS PHARMACOL SCI
JF - TRENDS PHARMACOL SCI
SN - 0165-6147
IS - 6
ER -